IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Northpond Ventures, LLC

Q4 2021 Holdings

Filed 2022-02-15 | 4 holdings | $15.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Candel Therapeutics Inc(CADL)COM137404109$15.1M1,935,21598.2%
Codex DNA IncCOM192003101$106.3K9,844,1300.7%
Dice Therapeutics IncCOM23345J104$83.3K3,292,8710.5%
Isoplexis CorpCOM465005106$80.9K8,805,2720.5%